Published: August 2025 | Last updated: May 2026
Many women who have sex with women have never been offered an STI test. The gap usually starts in the exam room: providers assume "low-risk" because there are no male partners, and the conversation ends before it begins. The assumption is wrong. STIs spread through skin contact, fluid exchange, and shared sex toys, and queer hookups involve all three.
This guide is for queer, lesbian, and bisexual women who want clear information about which infections actually move between female partners, what symptoms can mean, and how to ask for the testing you need without being dismissed. It also covers the cervical screening (Pap smears, HPV testing) that current public-health guidance recommends regardless of partner gender, plus the at-home options for anyone who would rather skip the gatekeeping entirely.
The Myth That Keeps Queer Women Undiagnosed
The myth doing the damage is some version of "lesbians don't get STIs." It's wrong on the science, and it's been wrong for decades. Studies of provider behavior in primary care and OB/GYN settings consistently find that women who have sex with women (WSW) are asked fewer sexual-history questions, are offered fewer STI tests, and have lower rates of cervical screening than women who report male partners. The clinical guidance does not support that gap.
The CDC's STI treatment guidelines explicitly state that WSW should not be presumed low-risk based on orientation, and recommend the same screening as for any sexually active adult, tailored to specific exposure routes (CDC STI treatment guidelines for WSW). When the system fails on this, infections go undiagnosed for months or years, sometimes long enough to cause downstream complications: cervical dysplasia from HPV, recurring bacterial vaginosis that resists treatment because both partners aren't being treated, herpes that's transmitted before the carrier knew they had it.
If you've been turned away from a panel because of who you sleep with, the problem is clinical assumption, not clinical guidance. The next sections cover what spreads, what symptoms can mean, and how to push for the screening you need.
The CDC's STI treatment guidelines explicitly include a section addressing women who have sex with women. The guidance is that orientation is not a reliable proxy for risk, and that screening should be based on the exposure routes the patient reports. If a clinician declines a panel on the basis of partner gender, that decision is not aligned with the published recommendations.
Which STIs Spread Between Women, and How
Almost every common STI can move between women through some combination of oral, manual, or toy-mediated contact. Frequency varies by infection; even the less-documented routes have confirmed cases. The infections worth knowing about:
- HPV (Human Papillomavirus): Spreads through genital skin-to-skin contact and oral-genital sex. Detected in a substantial fraction of WSW with no history of male partners. Some strains drive cervical, vaginal, vulvar, anal, and oropharyngeal cancers (CDC HPV).
- Herpes (HSV-1 and HSV-2): Transmits through direct skin-to-skin contact in the affected area, including during asymptomatic viral shedding. Oral-to-genital contact is a recognized HSV-1 route (CDC genital herpes).
- Bacterial vaginosis (BV): Not classified as an STI in the strict sense, but consistently more common in women whose partners are women, with high concordance rates between female partners (CDC BV). It causes the most frequent unusual-discharge complaints in this population.
- Trichomoniasis: Less common than in mixed-sex populations, but documented through shared toys and fluid exchange. Often asymptomatic in carriers.
- Chlamydia and gonorrhea: Less frequent than in heterosexual transmission, but possible through oral, finger, or toy-based exposure. Pharyngeal gonorrhea, in particular, can come from oral sex.
- HIV: Per-act transmission risk between female partners without blood-contact routes is very low and rarely documented. Risk rises with menstrual blood exposure, broken skin or shared sex toys used vaginally then anally, and shared injection equipment, and it is also non-zero when one partner has had recent unprotected contact outside the relationship. Testing windows: HIV RNA PCR detects infection from roughly 10 days post-exposure, fourth-generation antigen/antibody combo tests from about 18 to 45 days, and standard antibody tests by about 90 days.
- Syphilis, hepatitis B and C: Documented but uncommon between female partners. Risk concentrates in shared injection practices, blood-to-blood contact, or partners with broader sexual networks.
The shared logic: if there's contact, fluid, or friction, there's a transmission pathway. Saying "we're both women" is not the same as saying "we're both negative."
How Transmission Works Between Women
The myth that STIs require penis-in-vagina sex is part of a wider gap in sex education, where queer realities are either skipped entirely or hand-waved. The mechanics are not mysterious. Most queer hookups include several of these contact types in a single session:
- Oral sex: Saliva and the oral mucosa transmit HSV (especially HSV-1), HPV, and pharyngeal gonorrhea. Mouth-to-vulva contact also exposes the receiving partner to anything in the giver's saliva.
- Manual sex (fingering, fisting): Microtears in the vaginal or anal lining allow viral and bacterial transfer. Hands carry pathogens between bodies, and between body sites on the same body.
- Shared sex toys: A toy used vaginally on one partner and then on another, without cleaning or a fresh barrier, can transmit BV, trichomoniasis, HPV, and HSV. Toys passed between vaginal and anal use carry additional risk for bacterial transfer.
- Skin-to-skin contact: Herpes and HPV do not require fluid exchange. Genital-to-genital rubbing (sometimes called "scissoring") creates direct mucosal contact and transmission risk.
- Menstrual blood: Adds bloodborne-pathogen risk (HIV, hepatitis) to any of the above when one partner is menstruating, particularly with broken skin or no barriers.
None of this means queer sex is uniquely dangerous. It means the same hygiene and screening logic that applies to any sexually active person applies here. The default assumption should be "test based on what you have done," not "test based on the gender of who you have done it with."
- Oral-genital contact: HSV, HPV, pharyngeal gonorrhea or chlamydia
- Manual contact (fingers, fisting): viral and bacterial transfer through microtears
- Shared toys without barriers: BV, trichomoniasis, HPV, HSV
- Genital skin-to-skin contact: HPV and HSV without fluid exchange
- Menstrual blood exposure: bloodborne-pathogen risk on top of the above
Symptoms That Deserve Attention
Many STIs are silent in the carrier and visible only when transmitted. Silent infections are the reason routine screening matters. Still, certain patterns are worth a same-week visit, even if a partner has no symptoms:
- Unusual discharge or odor that persists beyond your usual cycle window. A persistent fishy odor is a classic BV sign; thicker, frothy, or yellow-green discharge can suggest trichomoniasis.
- Painless ulcers, sores, or blisters on the vulva, perineum, anal area, or mouth. Painlessness is not reassuring: primary syphilis chancres and some early HSV lesions are notably painless.
- Itching, burning, or new pelvic pain, especially after a recent new partner. Pelvic pain that worsens with bowel movements or sex can signal pelvic inflammatory disease (PID) from chlamydia or gonorrhea.
- Throat soreness or swollen neck lymph nodes after oral sex, sometimes the only sign of pharyngeal gonorrhea or HSV-1.
- Post-coital bleeding or any spotting outside your normal cycle, which can reflect cervical inflammation from chlamydia, HPV-related lesions, or other cervical pathology.
None of these symptoms are diagnostic on their own; many have non-STI causes (yeast, hormonal cycling, irritation from new soaps or lubes). The point is to test rather than guess. Same-day walk-in clinics and at-home rapid kits both eliminate the lag between symptom and result.
Painless genital ulcers, persistent unexplained pelvic pain, or new fevers and swollen lymph nodes after a recent exposure should prompt clinical evaluation within days, not weeks. Primary syphilis, acute HIV, and pelvic inflammatory disease are easier to treat early. If a clinic dismisses your concern, ask for the test in writing or seek a second opinion.
The Provider-Bias Problem in Queer Sexual Health
Provider behavior is one of the largest gaps in queer sexual healthcare. Surveys of WSW patients consistently report being asked fewer questions about activity, being skipped for routine cervical screening, and being offered narrower STI panels than their straight peers. Some clinicians do not know the screening guidance for WSW. Others assume a question about "partners" means men by default and never follow up. The result, documented in the CDC's own treatment guidelines, is under-testing in a population that has measurable rates of HPV, BV, herpes, and other infections.
Two patterns drive most of the dismissals: assuming orientation predicts behavior (it does not, since queer women have varied sexual histories that may include past or current male partners), and assuming "lower frequency" means "no risk." The CDC has explicitly addressed this in its STI screening guidance for WSW.
Effective screening requires that care providers and their female patients engage in a comprehensive and open discussion of sexual and behavioral risks that extends beyond sexual identity.
How to Ask for the Testing You Need
If a provider hesitates or tries to skip a panel, you have a right to push back. Direct, specific language tends to work better than vague requests. Some scripts that hold up in real visits:
- Lead with activity, not orientation: "I'd like a full STI panel, including HPV and herpes screening if appropriate. I've had oral and manual sex with female partners in the past year, and I want testing that matches that exposure."
- Name the tests: "Please include chlamydia and gonorrhea (vaginal and pharyngeal swabs if I've had oral exposure), trichomoniasis, HSV serology if I've had a possible exposure or sores, HIV, and syphilis. If I'm due for it, I'd also like a Pap smear and HPV co-test."
- Push back on assumption-based denials: "Risk comes from activity, not partner gender. The CDC's STI treatment guidelines specifically address screening for women who have sex with women. Please document the recommendation and the response in my chart."
- Switch providers if you have to: LGBT-affirming clinics exist in most metro areas. The GLMA "find a provider" directory and Planned Parenthood are reasonable starting points. Asking your insurer for an in-network LGBT-affirming primary care provider is a normal, valid request.
If a clinic still refuses, your other options are at-home rapid kits or a different provider. Neither requires arguing with anyone about your sex life.
Pap Smears and HPV Screening: Still Essential
One of the most common dismissals: "you don't need a Pap if you've never been with a man." It's wrong, and it has driven measurable cervical cancer disparities in this population. HPV spreads through genital skin contact and oral-genital sex, so it can be present in any cervix that has been sexually active, regardless of partner gender. Detection studies in WSW with no history of male partners still find HPV at meaningful rates.
Current screening guidance from major U.S. bodies (USPSTF, ACOG, ACS) for anyone with a cervix:
- Ages 21 to 29: Cervical cytology (Pap) every 3 years.
- Ages 30 to 65: Pap and HPV co-testing every 5 years, OR Pap alone every 3 years, OR primary HPV testing every 5 years (per ACS-aligned guidance).
- Over 65 or post-hysterectomy: Discontinuation criteria depend on prior screening history and clinical context; consult your provider.
If you have had any genital or oral-genital contact, you fall under the same screening recommendations as anyone else with a cervix. Skipping that screening based on partner gender is not aligned with current guidance (USPSTF cervical cancer screening recommendation).
This article is published by stdrapidtestkits.com, which sells at-home STI testing kits, including the products linked below. We recommend products based on fit-for-purpose for the reader's concern, not commercial benefit.
Safer-Sex Tools That Reduce Risk
Barrier methods for queer sex are real, available, and underused. None of them require killing the mood. The point is to make them part of how you set up a hookup, not a mid-act apology:
- Dental dams for oral-vulva or oral-anal contact. A cut-open external condom or a non-microwaved sheet of plastic wrap works in a pinch (the latter is not FDA-cleared for this use, but is widely cited in harm-reduction guidance as better than nothing).
- Latex or nitrile gloves for fingering, fisting, or any manual play involving broken skin or hangnails. They prevent transfer in both directions and reduce friction-related microtears.
- External condoms on shared toys: change them between partners and between body sites (vaginal versus anal) on the same body. Silicone toys can be sterilized between uses with hot water; porous materials cannot be reliably disinfected.
- Toy hygiene: hot water and antibacterial soap is fine for non-porous toys; bleach-water solution or boiling for thorough disinfection of compatible materials.
- Communication as protection: when did you last test? Anything new since? Any symptoms? "Where are you in your cycle?" is a normal question between people who have penetrative or oral contact.
None of these are perfect. Layered together, they meaningfully cut transmission risk for HSV, HPV, BV, trichomoniasis, and gonorrhea or chlamydia.
Telling a Partner About a Positive Result
Disclosure conversations are uncomfortable, and they're also non-optional from a public-health and ethical standpoint. The conversation usually goes better than the dread suggests. Some patterns that work:
- Lead with information, not blame: "I tested positive for [X]. Many of these infections are silent for months or longer, so I can't say with certainty when or how I got it. I wanted you to know so you can get tested and treated if needed."
- Offer the practical next step: a clinic referral, a link to an at-home kit, or the name of an STI hotline. Decision fatigue is real; reduce the friction.
- Skip the moralizing: STIs are an outcome of common human activity, not a character flaw. Treating it that way in conversation makes the other person more likely to test, treat, and disclose to their own partners.
- Give space: anger or fear often comes first. Compassion usually comes second. If a partner reacts cruelly, that response tells you something useful about the relationship.
For some infections (HIV, syphilis, gonorrhea, chlamydia), partner notification is a mandatory public-health function and your local health department can do it anonymously on your behalf. Ask your provider whether that option applies to your diagnosis.
In every U.S. state, certain STI diagnoses (HIV, syphilis, gonorrhea, chlamydia) are reportable to the local health department, and the department can notify former partners on your behalf without revealing your identity. If a direct conversation feels unsafe or impossible, ask your clinician about Disease Intervention Services (DIS) or the equivalent program in your area.
At-Home Testing as a Private Alternative
For anyone tired of explaining their sex life to skeptical providers, at-home rapid kits remove the gatekeeping. They are screening tools, not diagnostic confirmations, but they answer "should I follow up with a clinic?" without requiring a clinic visit to find out. The trade-offs:
- What at-home rapid kits do well: lateral-flow detection of HPV, herpes antibodies, HIV, syphilis, and hepatitis B and C from a fingerstick blood sample, plus chlamydia, gonorrhea, and trichomoniasis from a self-collected vaginal swab. Results in roughly 15 minutes.
- What they don't replace: cervical cytology (Pap), bacterial vaginosis evaluation, lab-grade NAAT confirmation of pharyngeal or rectal gonorrhea or chlamydia, or anything requiring a speculum exam. A reactive at-home result should be followed by a clinic confirmation.
- Privacy: discreet packaging, no lab requisition, no pharmacy pickup conversation.
For queer women whose primary obstacle is provider dismissal, this can be the most reliable way to get tested. The 10-in-1 women's kit covers the panel most relevant to WSW exposure routes in a single box.
Bottom Line: Your Sex Life Deserves Real Care
The "low-risk lesbian" myth has cost real diagnoses, real cervical screenings, and real treatment delays. It is not your job to teach your provider the CDC's WSW screening guidelines, but it can become your job to advocate for the panel that fits your activity. Test based on what you have done. Ask explicitly for HPV, herpes, BV evaluation if symptoms warrant, and the cervical screening that's recommended for any cervix.
If your provider refuses, you have alternatives: a different provider, an LGBT-affirming clinic, or an at-home rapid panel. None of those options require an argument.
FAQs
- Can lesbian and queer women really get STIs?
- Yes. HPV, herpes, bacterial vaginosis, and trichomoniasis are documented between female partners; chlamydia, gonorrhea, syphilis, and HIV are less common but possible. Risk follows activity (oral, manual, toy-mediated, skin-to-skin contact), not partner gender.
- Which STIs are most common in women who have sex with women?
- HPV and bacterial vaginosis lead the list. Herpes (especially HSV-1 from oral-genital contact) is also frequent. Chlamydia, gonorrhea, and trichomoniasis are less common between women but documented through oral, manual, and toy exposures.
- Do I need a Pap smear if I've never had sex with a man?
- Yes. Current USPSTF and ACOG guidance recommends cervical cytology every 3 years from age 21 to 29, then Pap and HPV co-testing every 5 years from 30 to 65, regardless of partner gender. HPV spreads through genital skin contact and is found in WSW.
- Can BV pass between female partners?
- Yes. Studies show high concordance rates between female partners and elevated BV prevalence among WSW. Both partners may need treatment to avoid recurrence. Persistent fishy odor and thin gray discharge are classic signs worth a clinic visit.
- Are dental dams really necessary?
- They reduce, not eliminate, transmission risk for HSV, HPV, gonorrhea, and other infections during oral-vulva or oral-anal contact. Underused but useful, especially with new partners or when sores or symptoms are present. Cut-open condoms work in a pinch.
- How often should queer women get tested?
- At least once a year if sexually active, more often with multiple partners, new partners, shared toys, or any new symptoms. Cervical screening follows the standard schedule. After any new exposure of concern, follow window-period guidance for each test.
- Can I get tested at home without seeing a provider?
- Yes. At-home rapid lateral-flow kits screen for HPV, herpes, HIV, syphilis, hepatitis B and C, chlamydia, gonorrhea, and trichomoniasis. They are screening tools, not diagnostic confirmations; a reactive result should be confirmed with a clinical lab.
- What should I do if my provider refuses to order STI tests?
- State the request in chart-documented language tied to specific activity, ask for the refusal in writing, and consider switching providers. LGBT-affirming clinics exist in most metro areas, and at-home rapid kits remove the gatekeeping entirely.
- U.S. Centers for Disease Control and Prevention. STI Treatment Guidelines: Special Populations, Women Who Have Sex with Women. Source for screening recommendations, the no-low-risk-by-orientation principle, and the activity-based screening framework cited throughout this article.
- U.S. Centers for Disease Control and Prevention. Bacterial Vaginosis. Source for prevalence, transmission concordance among female partners, and symptom-presentation guidance.
- U.S. Centers for Disease Control and Prevention. Human Papillomavirus (HPV). Source for transmission routes, the cancer-driving high-risk strains, and the screening rationale for anyone with a cervix.
- U.S. Centers for Disease Control and Prevention. Genital Herpes. Source for HSV-1 and HSV-2 transmission via skin-to-skin contact and asymptomatic shedding.
- U.S. Preventive Services Task Force. Cervical Cancer: Screening. Source for the age-based Pap and HPV screening intervals cited above.
- National Health Service (UK). Sexually transmitted infections (STIs). Source for general transmission, symptom, and screening guidance referenced throughout.
